Related content

FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy

By Lavely W.C.   Delbeke D.   Greer J.P.   Morgan D.S.   Byrne D.W.   Price R.R.   Hallahan D.E.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 2, 2003-10 ,pp. : 307-315

Elsevier

Access to resources Recommend Favorite

Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy

By Correa Denise   Rocco-Donovan Mary   DeAngelis Lisa   Dolgoff-Kaspar Rima   Iwamoto Fabio   Yahalom Joachim   Abrey Lauren  

Journal of Neuro-Oncology, Vol. 91, Iss. 3, 2009-02 ,pp. : 315-321

Springer Publishing Company

Access to resources Recommend Favorite

Residual disease after chemotherapy in aggressive malignant lymphoma: The role of radiotherapy

By Avilés Agustin   Neri Natividad   Delgado Serafin   Pérez Felipe   Nambo M.   Cleto Sergio   Talavera Alejandra   Huerta-Guzmán Judith  

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 383-387

Humana Press, Inc

Access to resources Recommend Favorite

Five-Year Follow-Up Study of Saliva, Mutans Streptococci, Lactobacilli and Yeast Counts in Lymphoma Patients

By Meurman J.H.   Laine P.   Lindqvist C.   Teerenhovi L.   Pyrhonen S.  

European Journal of Cancer. Part B: Oral Oncology, Vol. 33, Iss. 6, 1997-11 ,pp. : 439-443

Elsevier

Access to resources Recommend Favorite

Changing Patterns of Prognosticators During 15-Year Follow-Up of Advanced Gastric Cancer after Radical Gastrectomy and Adjuvant Chemotherapy: A 15-Year Follow-Up Study at a Single Korean Institute

By Moon Yong  

Annals of Surgical Oncology, Vol. 14, Iss. 10, 2007-10 ,pp. : 2730-2737

Springer Publishing Company

Access to resources Recommend Favorite